argenx SE (NAS:ARGX)
$ 356.01 -3.47 (-0.97%) Market Cap: 21.22 Bil Enterprise Value: 18.74 Bil PE Ratio: 0 PB Ratio: 5.39 GF Score: 74/100

argenx SE at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 08, 2021 / 06:10PM GMT
Release Date Price: $267.79 (+2.88%)
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst

Hi, good afternoon, everyone. Apologies for the technical delays, but welcome to the originally scheduled 2:10 session at the 42nd Annual Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I cover both U.S. and European biopharma names here at the firm. It's my great pleasure to be hosting argenx today in a fireside chat. And with me, I'd like to welcome the company CEO, Tim Van Hauwermeiren; COO, Keith Woods; and Karl Gubitz, who was announced a week ago as the company's new CFO.

So with that, I want to welcome the 3 of you, and thank you for your participation.

Timothy Van Hauwermeiren
argenx SE - CEO & Executive Director

Thank you, Graig.

Questions & Answers

Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst

So for those who might be somewhat new to the argenx story, although

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot